Duodenal switch provides superior resolution of metabolic comorbidities independent of Weight Loss in the super-obese (BMI ≥ 50 kg/m2) compared with gastric bypass

Journal of Gastrointestinal Surgery

Volumn 14, Issue 2, 2010, Pages 211-220

  Prachand, Vivek N ^a   Ward, Marc ^b   Alverdy, John C ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bariatric surgery; Biliopancreatic diversion; Comorbidity resolution; Diabetes; Duodenal switch; Gastric bypass; Gastroesophageal reflux; Morbid obesity; Super obesity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BARIATRIC SURGERY; COMORBIDITY; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; METABOLIC DISORDER; METHODOLOGY; MIDDLE AGED; MORBID OBESITY; RETROSPECTIVE STUDY; STOMACH BYPASS; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; BARIATRIC SURGERY; COMORBIDITY; FEMALE; GASTRIC BYPASS; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; WEIGHT LOSS; YOUNG ADULT;

EID: 77951934340     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1101-6     Document Type: Article

References (42)

1. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-1727.
2. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
3. Sturm R. Increases in morbid obesity in the USA: 2000-2005. Public Health 2007; 121(7): 492-496.
4. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373(9669): 1083-1096.
5. Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007; 61(5): 737-747.
6. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008; 207: 928-934.
7. LABS Writing Group. Relationship of body mass index with demographic and clinical characteristics in the Longitudinal Assessment of Bariatric Surgery (LABS). SOARD 2008; 4(4): 474-480.
8. Gregg EW, Cheng YJ, Cadwell BL et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293(15): 1868-1874.
9. Alley DE, Chang VW. The changing relationship of obesity and disability, 1988-2004. JAMA 2007; 298(17): 2020-2027.
10. Maggard MA, Shugarman LR, Suttorp M et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-559.
11. National Institutes of Health Consensus Development Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med 1991; 115: 956-961.
12. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
13. Clegg AJ, Colquitt J, Sidhu MK et al. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2002; 6: 1-153.
14. Mason EE, Doherty C, Maher JW et al. Super obesity and gastric reduction procedures. Gastroenterol Clin North Am 1987; 6: 495-502.
15. Artuso D, Wayne M, Kaul A et al. Extremely high body mass index is not a contraindication to laparoscopic gastric bypass. Obes Surg 2004; 6: 750-754.
16. Bloosmston M, Zervos EE, Camps MA et al. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg 1997; 7: 414-419.
17. MacLean LD, Rhode B, Nohn CW. Late outcome of isolated gastric bypass. Ann Surg 2000; 231: 524-528.
18. Melton GB, Steele KE, Schweitzer MA, Lidor AO, Magnuson TH. Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg 2008; 12(2): 250-255.
19. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8: 267-282.
20. Marceau P, Biron S, Bourque RA et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg 1993; 3: 29-35.
21. Marceau P, Hould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947-954.
22. DeMeester TR, Fuchs KH, Ball CS et al. Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux. Ann Surg 1987; 206: 414-426.
23. Scopinaro N, Gianetta E, Civalleri D et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618-620.
24. Fazylov RM, Savel RH, Horovitz JH et al. Association of super-superobesity and male gender with elevated mortality in patients undergoing the duodenal switch procedure. Obesity Surg 2005; 15: 618-623.
25. Dolan K, Hatzifotis M, Newbury L et al. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg 2004; 240: 51-56.
26. Slater GH, Ren CJ, Siegel N et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004; 8: 48-55.
27. 2) compared with gastric bypass. Ann Surg 2006; 244: 611-619.
28. Crémieux P, Buchwald H, Shikora SA et al. A study on the economic impact of bariatric surgery. Am J Manag Care 2008; 14(9): 589-596.
29. Williamson DF, Serdula MK, Anada RF, Levy A, Byers T. Weight loss attempts in adults: goals, duration, and rate of weight loss. Am J Pub Health 1992; 82: 1251-1257.
30. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. NIH Publication 1998 No. 98-4083.
31. Schauer P, Ikramuddin S, Gourash W et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000; 232: 515-529.
32. Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005; 15: 408-416.
33. Anthone GJ, Lord RV, DeMeester TR et al. The duodenal switch operation for the treatment of morbid obesity. Ann Surg 2003; 238: 618-628.
34. Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, Biertho L, Simard S. Duodenal switch: long-term results. Obes Surg 2007; 17(11): 1421-1430.
35. Ali MR, Maguire MB, Wolfe BM. Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients. J Am Coll Surg 2006; 202: 70-77.
36. Kellogg TA, Andrade R, Maddaus M, Slusarek B, Buchwald H, Ikramuddin S. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass. Surg Obes Relat Dis 2007; 3(1): 52-57. discussion 58-9.
37. Savage AP, Adrian TE, Carolan G et al. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987; 28: 166-170.
38. Gutzwiller JP, Goke B, Drewe J et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999; 44: 81-86.
39. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987; 2: 1300-1304.
40. Morinigo R, Moize V, Musri M et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006; 91: 1735-1740.
41. Borg CM, le Roux CW, Ghatei MA et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006; 93: 210-215.
42. Clements RH, Gonzalez QH, Long CI et al. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 2004; 70: 1-4.